Omalizumab as a Therapeutic Option for Nasal Polyposis in Moderate-to-Severe Persistent Allergic Asthma: Evidence From a Prospective Study in a Real-World Setting.
J Investig Allergol Clin Immunol · Autores del servicio: María José Hernández García
Perfil científico y docente
1 publicaciones verificadas en el inventario del servicio; periodo 2020–2020.
J Investig Allergol Clin Immunol · Autores del servicio: María José Hernández García